BREAST
| Diagnosis |
Investigator/Sponsor |
Protocol Title & Purpose |
Eligibility |
| Registry |
TME Research
TMENEO-100-3
NCT02596724
|
TME Neo-Adjuvant Breast Registry (The NEAT Registry) |
- Ages 18- 90 years
- Patients with histologically proven invasive breast cancer who have started
or are scheduled to start neo-adjuvant chemotherapy or endocrine therapy
|